Wolman disease - PDFSEARCH.IO - Document Search Engine

Wolman disease
Results: 19

#	Item
1	Attachment 1 Evaluation Test Name number as assigned during the Add to Reading List Source URL: www.engage.england.nhs.uk Language: English - Date: 2015-03-24 06:50:34 Lipid storage disorders Medical genetics Syndromes Genetic testing Prenatal diagnosis Cholesteryl ester storage disease Preimplantation genetic diagnosis Wolman disease Lysosomal Acid Lipase Deficiency Health Medicine Rare diseases
2	A Phase III Multicenter Study of SBC-‐102 (sebelipase alfa) in patients with Lysosomal Acid Lipase (LAL) Deficiency. Lysosomal Acid Add to Reading List Source URL: www.raredisorders.ca Language: English - Date: 2013-04-09 16:16:18 Medicine Cholesteryl ester storage disease Lysosomal Acid Lipase Deficiency Lipase Cirrhosis Hyperlipidemia Wolman Rare diseases Health Lipid storage disorders
3	SYNAGEVA BIOPHARMA™ HIGHLIGHTS DATA AT THE INTERNATIONAL CONGRESS OF INBORN ERRORS OF METABOLISM LEXINGTON, Mass., September 4, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company dev Add to Reading List Source URL: www.synageva.com Language: English - Date: 2013-09-04 07:10:51 Medicine Syndromes Hepatology Lysosomal Acid Lipase Deficiency Cholesteryl ester storage disease Wolman disease Sanfilippo syndrome Hunter syndrome Lysosomal storage disease Health Rare diseases Lipid storage disorders
4	SYNAGEVA BIOPHARMA™ REPORTS 2013 FULL YEAR FINANCIAL RESULTS LEXINGTON, Mass., March 3, [removed]Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-03-03 16:19:48 Lysosomal Acid Lipase Deficiency Wolman disease Cholesteryl ester storage disease Lysosomal storage disease Mucopolysaccharidosis Rare diseases Lipid storage disorders Health
5	SYNAGEVA BIOPHARMA™ ANNOUNCES PRESENTATIONS AND A SATELLITE SYMPOSIUM AT THE NATIONAL LIPID ASSOCIATION MEETING LEXINGTON, Mass., May 31, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical c Add to Reading List Source URL: www.synageva.com Language: English - Date: 2013-05-31 11:41:10 Medicine Lysosomal Acid Lipase Deficiency Cholesteryl ester storage disease Wolman disease Lysosomal storage disease Mucopolysaccharidosis Lysosomal lipase Sanfilippo syndrome Atherosclerosis Health Rare diseases Lipid storage disorders
6	LATE ONSET LAL DEFICIENCY (CESD) LITERATURE REVIEW PUBLISHED IN THE JOURNAL OF HEPATOLOGY LEXINGTON, Mass., March 26, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a clinical stage biopharmaceutical company Add to Reading List Source URL: www.synageva.com Language: English - Date: 2013-03-26 07:29:22 Rare diseases Hepatology Cardiology Lipoproteins Cholesteryl ester storage disease Wolman disease Lysosomal Acid Lipase Deficiency Cirrhosis Lysosomal storage disease Medicine Health Lipid storage disorders
7	SYNAGEVA BIOPHARMA™ HIGHLIGHTS SEBELIPASE ALFA AND LAL DEFICIENCY DATA AT THE LYSOSOMAL DISEASE NETWORK (LDN) WORLD SYMPOSIUM™ LEXINGTON, Mass., February 13, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-02-13 14:27:52 Medicine Lysosomal Acid Lipase Deficiency Wolman disease Cholesteryl ester storage disease Lysosomal storage disease Hunter syndrome Low-density lipoprotein Mucopolysaccharidosis Cirrhosis Health Rare diseases Lipid storage disorders
8	SYNAGEVA BIOPHARMA™ HIGHLIGHTS SBC-103 DATA AT THE LYSOSOMAL DISEASE NETWORK (LDN) WORLD SYMPOSIUM™ LEXINGTON, Mass., February 12, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical compan Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-02-12 15:27:02 Syndromes Sanfilippo syndrome Wolman disease Mucopolysaccharidosis Cholesteryl ester storage disease Lysosomal storage disease Hunter syndrome Blood–brain barrier Health Rare diseases Lipid storage disorders
9	SYNAGEVA BIOPHARMA™ REPORTS SECOND QUARTER 2014 FINANCIAL RESULTS LEXINGTON, Mass., July 30, [removed]Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-08-04 12:07:09 Lysosomal Acid Lipase Deficiency Wolman disease Cholesteryl ester storage disease Mucopolysaccharidosis Hunter syndrome Health Rare diseases Lipid storage disorders
10	SYNAGEVA BIOPHARMA™ ISSUED U.S. PATENT FOR TREATMENT OF LAL DEFICIENCY LEXINGTON, Mass., March 4, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-03-04 08:05:19 Lysosomal Acid Lipase Deficiency Wolman disease Cholesteryl ester storage disease Lysosomal storage disease Mucopolysaccharidosis Sanfilippo syndrome Acid lipase disease Wolman Rare diseases Health Lipid storage disorders